Zobrazeno 1 - 10
of 18
pro vyhledávání: '"I V, Bure"'
Autor:
E. A. Vetchinkina, A. I. Kalinkin, E. B. Kuznetsova, A. E. Kiseleva, E. A. Alekseeva, M. V. Nemtsova, I. V. Bure
Publikováno v:
Успехи молекулярной онкологии, Vol 9, Iss 4 (2022)
Introduction. Gastric cancer remains one of the most common cancers and has a high mortality rate worldwide. Epigenetic alternations of non-coding RNAs (ncRNAs), including microRNAs and long ncRNAs can contribute to its pathogenesis and progression,
Externí odkaz:
https://doaj.org/article/8bba5b332d164bb9a04d0337b716d679
Autor:
M. V. Nemtsova, I. V. Bure
Publikováno v:
Advances in Molecular Oncology. 10:8-17
Chromatin remodeling is the one of the main epigenetic ways of gene expression regulation both in normal cells and in oncological diseases. Genes encoding protein subunits of SWI/ SNF remodeling complexes often mutate and/or change their expression i
Publikováno v:
Терапевтический архив, Vol 91, Iss 8, Pp 115-117 (2019)
MicroRNAs are short non - coding RNAs that correlate with the levels of platelet activation which can be utilized as a biomarker when guiding P2Y12 inhibitors therapy. In this literature review, the perspectives of microRNA as a novel biomarker are d
Externí odkaz:
https://doaj.org/article/13c20a5908d3440da3c218e1ad40bc5c
Autor:
Evgeniy Bryun, Sergey S. Koporov, Michael S. Zastrozhin, I V Bure, Pavel Golovinskii, Elena A. Grishina, V. V. Smirnov, Kristina A Ryzhikova, Dmitry A. Sychev, Valentin Yurievich Skryabin, Anastasiya Zastrozhina
Publikováno v:
American Journal of Therapeutics. 29:e26-e33
BACKGROUND Previous studies have shown that cytochrome P450 2D6 (CYP2D6) is involved in the metabolism of fluvoxamine, the activity of which is highly dependent, inter alia, on the polymorphism of the gene encoding it. The objective of our study was
Autor:
D. S. Mikhaylenko, S. A. Sergienko, E. B. Kuznetsova, I. N. Zaborsky, M. I. Martynov, O. B. Loran, G. D. Efremov, S. A. Samoylova, B. Ya. Alekseev, V. V. Musatova, I. V. Bure, M. V. Nemtsova
Publikováno v:
Onkourologiâ, Vol 17, Iss 1, Pp 89-100 (2021)
Background. Bladder cancer (BC) is a common urological cancer, 75 % of which are non-muscle invasive BC. After removal of the primary tumor, the adequate classification of malignancy and the defining of tumor progression risk remains an important iss
Autor:
I V Bure, Vitaliy A. Otdelenov, D. V. Ivashchenko, Eric Rytkin, K. B. Mirzaev, Igor N. Sychev, Dmitry A. Sychev
Publikováno v:
Annals of the Russian academy of medical sciences. 74:299-306
One of the main causes for adverse reactions development is not taking into account the pharmacokinetics of drugs and the dose. Pharmacokinetics of drugs is mostly defined by the cytochrome P-450 isoenzymes activity, carboxylesterases and many other
Autor:
M S, Zastrozhin, A V, Efimova, VYu, Skryabin, V V, Smirnov, A E, Petukhov, E P, Pankratenko, S A, Pozdniakov, E V, Kaverina, D A, Klepikov, E A, Grishina, K A, Ryzhikova, I V, Bure, E A, Bryun, D A, Sychev
Publikováno v:
Psychopharmacol Bull
INTRODUCTION: Phenazepam is commonly administered to patients diagnosed with major depressive disorder. Some proportion of such patients do not show adequate response to treatment regimen containing phenazepam, whereas many of them experience type A
Autor:
Elena Aleshkovich, Valery V. Smirnov, A. A. Kachanova, Denis Andreev, I V Bure, K. B. Mirzaev, Dmitry A. Sychev, Alexey Shabunin, Elena A. Grishina, K. A. Akmalova, Nataliya Lyakhova, Anna G Saribekian, Eric Rytkin, Sherzod Abdullaev
Publikováno v:
Pharmacogenomics and Personalized Medicine
Eric Rytkin,1 Karin Mirzaev,1 Irina Bure,1 Kristina Akmalova,1 Sherzod Abdullaev,1 Anastasiia Kachanova,1 Valery Smirnov,2,3 Elena Grishina,1 Natalia Lyakhova,4 Elena Aleshkovich,4 Anna Saribekian,2 Denis Andreev,2 Alexey Shabunin,4 Dmitry Sychev1 1I
Autor:
M S, Zastrozhin, VYu, Skryabin, VYu, Smirnov, A K, Zastrozhina, E V, Kaverina, D A, Klepikov, E A, Grishina, K A, Ryzhikova, I V, Bure, E A, Bryun, D A, Sychev
Publikováno v:
Psychopharmacol Bull
INTRODUCTION: Mirtazapine is commonly administered to patients with recurrent depressive disorder. Some of these patients do not show adequate response to the therapy with mirtazapine, whereas many of them experience dose-dependent adverse drug react
Publikováno v:
Molecular Biology. 52:787-798